American Financial Group Inc vs Neurocrine Biosciences Inc — how do they compare? American Financial Group Inc trades at $144.65 (market cap $11.97B), while Neurocrine Biosciences Inc trades at $157 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is the larger of the two by market cap, and American Financial Group Inc pays a 2.44% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| AFG | NBIX | |
|---|---|---|
Market Cap | $11.97B | $16.46B |
Sector | Financials | Health |
52-Week High | $148.71 | $185.50 |
52-Week Low | $124.18 | $123.10 |
Enterprise Value | $12.35B | $16.48B |
Dividend Yield | 2.44% | — |
Trailing returns across standard periods
American Financial Group Inc is a holding company that is engaged primarily in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. American also has annuity operations that are focused on sales of traditional fixed and fixed-indexed annuities in the education, bank, and individual markets. American's insurance operations are conducted through the Great American Insurance Group. The group writes business in all 50 of the United States, primarily through independent agents and brokers.
Read more on AFG →Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →